JP Morgan: Raises target price for HK & CHINA GAS (00003) to HKD 7.75, rating upgraded to "Overweight."
Morgan Stanley has raised its earnings per share forecast for Gas in 2026-2027 by 5.7% and 4.4%, respectively, to HK$0.34, to reflect higher profit assumptions for sustainable aviation fuel. The firm also anticipates that if the company's earnings growth momentum can be sustained, it may consider increasing the dividend per share.
JPMorgan released a research report stating that HK & CHINA GAS (00003) has underperformed its peers by approximately 15% year-to-date, due to market concerns over weak profitability in its Chinese operations. However, the companys better-than-expected performance in the first half of the year is likely to ease these concerns and drive the stock price up. The target price has been raised from HKD 7.3 to HKD 7.75, and the rating has been upgraded from "Neutral" to "Overweight." JPMorgan has also raised its earnings per share estimates for the company by 5.7% and 4.4% for 2026-2027, to HKD 0.34, reflecting higher profit assumptions for sustainable aviation fuel. Additionally, it is anticipated that if the company's profit growth momentum can be sustained, it may consider increasing the dividend per share.
Related Articles

HK Stock Market Move | XXF (02473) fell over 3%, expecting a mid-term profit attributable to shareholders of at least approximately 16.5 million yuan. Revenue from automotive retail and financing businesses decreased year-on-year.

HK Stock Market Move | ZAI LAB (09688) rose nearly 7% in early trading as argenx's FcRn-targeted drug achieved success in its Phase 3 trial. Zai Lab holds the rights for the Greater China region.

HK Stock Market Move | CHINA QINFA (00866) rises nearly 8% again, with earnings in the first half not exceeding 290 million yuan. Indonesia plans to establish a commodity exchange.
HK Stock Market Move | XXF (02473) fell over 3%, expecting a mid-term profit attributable to shareholders of at least approximately 16.5 million yuan. Revenue from automotive retail and financing businesses decreased year-on-year.

HK Stock Market Move | ZAI LAB (09688) rose nearly 7% in early trading as argenx's FcRn-targeted drug achieved success in its Phase 3 trial. Zai Lab holds the rights for the Greater China region.

HK Stock Market Move | CHINA QINFA (00866) rises nearly 8% again, with earnings in the first half not exceeding 290 million yuan. Indonesia plans to establish a commodity exchange.

RECOMMEND





